Atria Wealth Solutions’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-8,740
| Closed | -$558K | – | 1860 |
|
2025
Q1 | $558K | Sell |
8,740
-2,952
| -25% | -$188K | 0.01% | 1144 |
|
2024
Q4 | $1.42M | Buy |
11,692
+1,108
| +10% | +$135K | 0.02% | 775 |
|
2024
Q3 | $1.32M | Sell |
10,584
-325
| -3% | -$40.6K | 0.01% | 810 |
|
2024
Q2 | $1.72M | Sell |
10,909
-300
| -3% | -$47.4K | 0.02% | 677 |
|
2024
Q1 | $1.45M | Sell |
11,209
-1,550
| -12% | -$201K | 0.02% | 746 |
|
2023
Q4 | $1.23M | Buy |
12,759
+665
| +5% | +$64.1K | 0.02% | 777 |
|
2023
Q3 | $1.47M | Sell |
12,094
-421
| -3% | -$51K | 0.02% | 664 |
|
2023
Q2 | $1.43M | Sell |
12,515
-1,438
| -10% | -$165K | 0.02% | 693 |
|
2023
Q1 | $1.92M | Sell |
13,953
-1,682
| -11% | -$232K | 0.03% | 550 |
|
2022
Q4 | $2.03M | Buy |
15,635
+1,618
| +12% | +$210K | 0.03% | 509 |
|
2022
Q3 | $1.55M | Sell |
14,017
-1,105
| -7% | -$122K | 0.03% | 566 |
|
2022
Q2 | $1.13M | Buy |
15,122
+1,641
| +12% | +$123K | 0.02% | 629 |
|
2022
Q1 | $1.05M | Buy |
+13,481
| New | +$1.05M | 0.02% | 708 |
|